Abstract
The UK Health Security Agency (UKHSA)’s Knowledge and Library Services (KLS) established an Artificial Intelligence (AI) working group in 2022 to explore potential applications of AI of relevance to its function. This paper describes the working group’s approach to testing and evaluating AI and machine learning-assisted tools for information retrieval and evidence review processes, including duplicate reference removal, citation searching, title and abstract screening, full text screening, data extraction and critical appraisal. Initial tests have demonstrated varying degrees of potential for implementation, while also contributing to broader discussions on ethical considerations, copyright and licensing issues, transparency of AI methodology and evidence integrity. This overview outlines the methodology used and insights gained from navigating the rapidly evolving AI landscape and its potential implications for knowledge and library services within a public health organisation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors received no financial support for the research, authorship or publication of this article.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data used in this paper is available from the corresponding author.
